QUOTE AND NEWS
Benzinga  Jul 19  Comment 
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) and Eisai Inc. revealed that the Food and Drug Administration has approved its New Drug Application (NDA) for BELVIQ XR (lorcaserin HCl) CIV extended-release 20 mg tablets. According to the company, the...
MarketWatch  Jul 19  Comment 
Arena Pharmaceuticals Inc. shares rose 8.8% in pre-market trade Tuesday after the company said its weight-loss drug with Eisai Inc. received Food and Drug Administration approval. Eisai shares were up 4.0% in pre-market trade after the news. The...
Benzinga  Jul 14  Comment 
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) and Eisai Inc. revealed Thursday that the Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) has given its approval for the chronic weight management agent VENESPRI. It would proceed...
MarketWatch  Jun 30  Comment 
Shares of Arena Pharmaceuticals Inc. were halted in the extended session Thursday after the biotech said it was reducing its workforce by 73% to focus on drugs in development. Arena shares were halted at $1.83 after hours. The company said it was...
Benzinga  Jun 15  Comment 
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) revealed Wednesday that Kevin Lind would join its management team as EVP and CFO effective June 15, 2016. According to the company, Lind would report to Amit Munshi, its President and CEO. Munshi...
Benzinga  Jun 13  Comment 
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) revealed Monday that the United States Adopted Names (USAN) Council has approved the nonproprietary name etrasimod for APD334, a selective oral, investigational, Sphingosine 1-Phosphate Subtype 1 (S1P1)...
Motley Fool  Jun 1  Comment 
Hint: It’s not obesity drug Belviq! Find out where investors should focus their attention instead.





 

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki